Lemonade Inc. (LMND) PT Raised to $28 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts LMND Hot Sheet
Price: $45.15 -2.82%
Rating Summary:
3 Buy, 7 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
3 Buy, 7 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
Barclays analyst Ross Sandler raised the price target on Lemonade Inc. (NYSE: LMND) to $28.00 (from $20.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $220 at BMO Capital
- Mirum Pharmaceuticals (MIRM) PT Raised to $184 at Citi
- Lemonade expands Tesla FSD insurance discount to HW3 vehicles
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
